Company: NCEL
Filing Date: 2025-03-31
Form Type: F-4/A
Source: 0001213900-25-026428
Chunk: 360

Company: NewcelX Ltd.
Filing Date: 2025-03-31
Form: F-4/A
Chunk 360
---
3.2million received by NLS on October10, 2024, in connection with the sale of 806,452 common shares and warrants to purchase an additional 806,452 common shares, at a combined purchase price of $3.97, October Equity Purchase Agreement. The warrants have a term of five years and an exercise price of $4.25 per share adjusted to $3.10 upon execution of the December SPA agreed on January9, 2025 to satisfy the anti -dilutionprovision; (B)To record gross proceeds of $786,662 in connection with the sale of 81,944 common shares at a purchase price of $9.60 per share on July1, 2024; (C)To record gross proceeds of $500,000 in connection with issuance of 161,290 common shares issued in a private placement pursuant to December 2024 securities purchase agreement agreed on January9, 2025; (D)To record gross proceeds of CHF 153,145 (“Exercise Price in USD of $168,980”) in connection with the issuance of 191,431 common shares due to exercise of pre -fundedwarrants provided to a certain institutional investor on September16, 2024 upon entering a warrant amendment agreement; (E)To record gross proceeds of $178,699 related to exercise of warrants for a total of 76,847 common shares in connection with October Equity Purchase Agreement and pre -fundedwarrants provided to certain institutional investors upon execution of warrant amendment agreements; (F)To record gross proceeds of $2,000,000 in connection with issuance of 1,212,122 Preferred Shares issued in a private placement offering with three accredited investor entered on March27, 2025 with a conversion price of $1.65 per share; (G)Adjustment to record satisfaction of $4.0million of Company debt by issuing 806,452 newly designated convertible preferred shares at a purchase and conversion price of $4.96 per share 806,452 in connection with a securities purchase agreement entered on October10, 2024 with an accredited investor. Upon execution of the December SPA agreed on January9, 2025 to satisfy the anti -dilutionand rachet rights the conversion price was adjusted to $3.10; 198 (H)Adjustments for reduction in $434,284 in accounts payable, $143,897 trade payables and $143,630 in accrued pension liability because of